MetLife Investment Management’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-15,424
| Closed | -$125K | – | 2508 |
|
|
2021
Q3 | $125K | Buy |
+15,424
| New | +$125K | ﹤0.01% | 2342 |
|
|
2021
Q2 | – | Sell |
-17,682
| Closed | -$153K | – | 2448 |
|
|
2021
Q1 | $153K | Buy |
17,682
+2,706
| +18% | +$23.5K | ﹤0.01% | 2180 |
|
|
2020
Q4 | $119K | Hold |
14,976
| – | – | ﹤0.01% | 2207 |
|
|
2020
Q3 | $119K | Hold |
14,976
| – | – | ﹤0.01% | 2132 |
|
|
2020
Q2 | $148K | Buy |
+14,976
| New | +$148K | ﹤0.01% | 2061 |
|
|
2019
Q3 | – | Sell |
-14,785
| Closed | -$97.7K | – | 2343 |
|
|
2019
Q2 | $97.7K | Hold |
14,785
| – | – | ﹤0.01% | 2376 |
|
|
2019
Q1 | $112K | Hold |
14,785
| – | – | ﹤0.01% | 2280 |
|
|
2018
Q4 | $119K | Hold |
14,785
| – | – | ﹤0.01% | 2208 |
|
|
2018
Q3 | $191K | Hold |
14,785
| – | – | ﹤0.01% | 2113 |
|
|
2018
Q2 | $169K | Buy |
+14,785
| New | +$169K | ﹤0.01% | 1994 |
|